BRM Statistics

Total Valuation

Bristol-Myers Squibb Company has a market cap or net worth of EUR 112.59 billion. The enterprise value is 153.65 billion.

Market Cap	112.59B
Enterprise Value	153.65B

Important Dates

The last earnings date was Thursday, October 31, 2024.

Earnings Date	Oct 31, 2024
Ex-Dividend Date	Oct 4, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.52%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.02B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.20, with an EV/FCF ratio of 12.42.

EV / Earnings	-23.61
EV / Sales	3.40
EV / EBITDA	8.20
EV / EBIT	17.91
EV / FCF	12.42

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 2.99.

Current Ratio	1.24
Quick Ratio	1.02
Debt / Equity	2.99
Debt / EBITDA	2.62
Debt / FCF	3.73
Interest Coverage	5.05

Financial Efficiency

Return on equity (ROE) is -31.33% and return on invested capital (ROIC) is 8.20%.

Return on Equity (ROE)	-31.33%
Return on Assets (ROA)	6.07%
Return on Capital (ROIC)	8.20%
Revenue Per Employee	1.25M
Profits Per Employee	-190,836
Employee Count	34,100
Asset Turnover	0.51
Inventory Turnover	3.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.26% in the last 52 weeks. The beta is 0.46, so Bristol-Myers Squibb Company's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	+21.26%
50-Day Moving Average	49.18
200-Day Moving Average	44.58
Relative Strength Index (RSI)	64.69
Average Volume (20 Days)	5,249

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.13

Income Statement

In the last 12 months, Bristol-Myers Squibb Company had revenue of EUR 42.53 billion and -6.51 billion in losses. Loss per share was -3.21.

Revenue	42.53B
Gross Profit	32.27B
Operating Income	8.06B
Pretax Income	-6.17B
Net Income	-6.51B
EBITDA	17.18B
EBIT	8.06B
Loss Per Share	-3.21

Full Income Statement

Balance Sheet

The company has 7.26 billion in cash and 46.12 billion in debt, giving a net cash position of -38.57 billion.

Cash & Cash Equivalents	7.26B
Total Debt	46.12B
Net Cash	-38.57B
Net Cash Per Share	n/a
Equity (Book Value)	15.42B
Book Value Per Share	7.58
Working Capital	4.87B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.45 billion and capital expenditures -1.08 billion, giving a free cash flow of 12.38 billion.

Operating Cash Flow	13.45B
Capital Expenditures	-1.08B
Free Cash Flow	12.38B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.87%, with operating and profit margins of 18.95% and -15.30%.

Gross Margin	75.87%
Operating Margin	18.95%
Pretax Margin	-14.50%
Profit Margin	-15.30%
EBITDA Margin	40.40%
EBIT Margin	18.95%
FCF Margin	29.10%

Dividends & Yields

Bristol-Myers Squibb Company does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	3.66%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	3.52%
Shareholder Yield	3.52%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bristol-Myers Squibb Company has an Altman Z-Score of 1.91. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.91
Piotroski F-Score	n/a